Skip to main content

Table 1 Recent development of drug delivery systems for liver fibrosis therapy

From: Co-delivery of miR-29b and germacrone based on cyclic RGD-modified nanoparticles for liver fibrosis therapy

Nanocarriers

Targeted molecules

Drugs

Reference

liposomes

Vitamin A

Imatinib

[10] (2017)

PLGA-PSPE-PEG NPs

Vitamin A

Silibinin & siCol1α1

[12] (2018)

CaP@BSA NPs

/

TSG-6

[35] (2020)

HA nanomicelles

Hyaluronic acid

Silibinin

[36] (2019)

PEG-PLGA NPs

Vitamin A

Nilotinib

[37] (2019)

CS nanomicelles

Chondroitin sulfate

Doxorubicin & retinoic acid

[38] (2019)

Lipid nanoparticles

Vitamin A

siCol1α1 & siTIMP-1

[39] (2020)

Liposomes

cRGDyK

Vismodegib

[40] (2019)

Polymeric micelles

/

Polydatin

[41] (2020)